Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,084
Total Claims
$2.7M
Drug Cost
141
Beneficiaries
$19K
Cost/Patient
Risk Score Breakdown 11/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1530%
Cost per patient vs peers
$19K vs $1,174 avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 0 claims · $0
Generic: 1,159 claims · $55K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 134 | $552K |
| Elviteg/Cob/Emtri/Tenof Alafen | 128 | $512K |
| Dolutegravir Sodium | 108 | $290K |
| Abacavir/Dolutegravir/Lamivudi | 61 | $233K |
| Dolutegravir/Rilpivirine | 65 | $225K |
| Darunavir/Cob/Emtri/Tenof Alaf | 45 | $205K |
| Emtricitabine/Tenofov Alafenam | 68 | $154K |
| Emtricita/Rilpivirine/Tenof Df | 23 | $88K |
| Emtricitab/Rilpiviri/Tenof Ala | 23 | $86K |
| Dolutegravir Sodium/Lamivudine | 25 | $76K |
| Darunavir/Cobicistat | 23 | $54K |
| Darunavir | 18 | $38K |
| Sitagliptin Phosphate | 17 | $13K |
| Apixaban | 17 | $11K |
| Budesonide/Formoterol Fumarate | 24 | $9,533 |
Prescribing Profile
Patient Profile
60
Avg Age
38%
Female
2.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About